G

Giant Biogene Holding Co Ltd
HKEX:2367

Watchlist Manager
Giant Biogene Holding Co Ltd
HKEX:2367
Watchlist
Price: 49.55 HKD -1.1%
Market Cap: 50.3B HKD
Have any thoughts about
Giant Biogene Holding Co Ltd?
Write Note

Gross Margin
Giant Biogene Holding Co Ltd

82.7%
Current
83%
Average
31.6%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
82.7%
=
Gross Profit
3.7B
/
Revenue
4.5B

Gross Margin Across Competitors

Country CN
Market Cap 51B HKD
Gross Margin
83%
Country FR
Market Cap 176.4B EUR
Gross Margin
74%
Country UK
Market Cap 113.2B GBP
Gross Margin
0%
Country IN
Market Cap 5.6T INR
Gross Margin
52%
Country UK
Market Cap 33.1B GBP
Gross Margin
62%
Country DE
Market Cap 27.9B EUR
Gross Margin
58%
Country US
Market Cap 23.3B USD
Gross Margin
72%
Country JP
Market Cap 2.9T JPY
Gross Margin
38%
Country IN
Market Cap 1.2T INR
Gross Margin
56%
Country IN
Market Cap 900.4B INR
Gross Margin
49%
Country US
Market Cap 9.4B USD
Gross Margin
34%

Profitability Report

View the profitability report to see the full profitability analysis for Giant Biogene Holding Co Ltd.

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
82.7%
=
Gross Profit
3.7B
/
Revenue
4.5B
What is the Gross Margin of Giant Biogene Holding Co Ltd?

Based on Giant Biogene Holding Co Ltd's most recent financial statements, the company has Gross Margin of 82.7%.